| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.620 | 29.890 | 29.289 | 35.109 | 42.372 | 44.958 | 37.986 | 48.842 | 55.540 | 68.290 |
| Total Income - EUR | 34.945 | 35.222 | 32.297 | 35.187 | 60.075 | 47.820 | 46.846 | 48.842 | 55.549 | 86.055 |
| Total Expenses - EUR | 19.480 | 19.606 | 18.713 | 12.098 | 32.969 | 18.416 | 26.427 | 24.323 | 52.448 | 55.308 |
| Gross Profit/Loss - EUR | 15.465 | 15.616 | 13.584 | 23.089 | 27.106 | 29.404 | 20.419 | 24.520 | 3.101 | 30.748 |
| Net Profit/Loss - EUR | 14.416 | 15.317 | 13.292 | 22.738 | 26.680 | 28.976 | 20.047 | 24.041 | 2.615 | 28.915 |
| Employees | 3 | 3 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Veramed Vantheocor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.727 | 10.860 | 13.546 | 13.263 | 31.162 | 33.432 | 40.643 | 39.679 | 69.912 | 88.403 |
| Current Assets | 40.785 | 52.681 | 46.464 | 67.025 | 74.833 | 99.371 | 63.973 | 40.188 | 12.858 | 15.156 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.031 | 0 |
| Receivables | 3.619 | 3.559 | 3.632 | 5.782 | 6.563 | 10.750 | 1.646 | 4.807 | 4.759 | 3.530 |
| Cash | 37.166 | 49.122 | 42.832 | 61.243 | 68.270 | 88.621 | 62.327 | 35.381 | 7.068 | 11.626 |
| Shareholders Funds | 42.545 | 57.427 | 54.754 | 76.487 | 101.624 | 128.674 | 101.394 | 24.090 | 26.631 | 56.916 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.967 | 6.114 | 5.256 | 3.801 | 4.371 | 4.130 | 3.222 | 55.778 | 56.139 | 46.643 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Veramed Vantheocor S.r.l.